Hosted on MSN26m
BNP PARIBAS EXANE Upgrades Novo Nordisk A (NVO)Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Neutral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback